SSY GROUP (02005): Acetylaminophenol tablets approved by the National Medical Products Administration for new 0.5g specification.
Sinopharm Group (02005) announced that the group's paracetamol tablets have been approved by the China National Medical Products Administration...
SSY GROUP (02005) announced that the group's paracetamol tablets have been approved by the National Medical Products Administration of China (NMPA) for a new 0.5g specification, and both the 0.3g and 0.5g paracetamol tablets have been approved by the NMPA for generic drug quality and therapeutic efficacy consistency evaluation.
Paracetamol tablets are mainly used for fever caused by common cold or influenza, and also used to relieve mild to moderate pain.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


